Table. 14—

Recommended treatment options(in no special order) for hospitalised patients with community-acquired pneumonia (C4)^#

Preferred^¶	Alternative⁺
Penicillin G±macrolide^ƒ	Levofloxacin^§
Aminopenicillin±macrolide^§,ƒ	Moxifloxacin^§,##
Aminopenicillin/β-lactamase inhibitor±macrolide^§,ƒ
Nonantipseudomonal cephalosporin II^ƒ or III±macrolide^ƒ

^#: experience with ketolides is limited, but they may offer an alternative when oral treatment is adequate; ^¶: in regions with low resistance rates; ⁺: in regions with increased resistance rates or intolerance to preferred drugs; ^§: can be applied as sequential treatment using the same drug; ^ƒ: new macrolides preferred to erythromycin; ^##: within the fluoroquinolones, moxifloxacin has the highest anti-pneumococcal activity.